» Articles » PMID: 30833332

Characterization of the Horizontal and Vertical Sexual Transmission of Genital Infections in a New Mouse Model

Overview
Journal Infect Immun
Date 2019 Mar 6
PMID 30833332
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

is the most common sexually transmitted bacterial pathogen worldwide, and there is a need to control this epidemic. So far there is no established animal model in which both the horizontal and the vertical transmission of can be studied. To implement a horizontal sexual transmission model, male mice were inoculated in the meatus urethra with and they were caged with naive female mice. Urine and vaginal swab specimens were collected for culture. To study vertical transmission, newborns were euthanized and specimens were cultured. As controls, females were mated with sham-infected male mice. All -inoculated male mice had positive urine cultures. As determined by serology, all females caged with -inoculated males became infected, and 93% of them had positive vaginal swab specimen cultures. More females mated with -infected male mice (35%) than females mated with sham-infected male mice (0%) were infertile (0.05). Also, -infected females delivered significantly fewer pups (3.8 ± 3.2/mouse) than control females (6.3 ± 1.6/mouse) (0.05). Of the newborn mice, 32% were positive either in the lungs or in the intestines. Female mice housed with sham-infected males had no positive vaginal swab specimen cultures or -positive pups. This new mouse model of horizontal and vertical sexual transmission of closely parallels sexual transmission in humans and may be a good model system to better understand the pathogenesis of these infections.

Citing Articles

Advances in vaccine development for Chlamydia trachomatis.

Poston T Pathog Dis. 2024; 82.

PMID: 39043447 PMC: 11338180. DOI: 10.1093/femspd/ftae017.


Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions.

Vacca F, Sala C, Rappuoli R Biomedicines. 2022; 10(9).

PMID: 36140226 PMC: 9496014. DOI: 10.3390/biomedicines10092126.


Reemergence of the Murine Bacterial Pathogen in Research Mouse Colonies.

Mishkin N, Ricart Arbona R, Carrasco S, Lawton S, Henderson K, Momtsios P Comp Med. 2022; 72(4):230-242.

PMID: 35803706 PMC: 9413529. DOI: 10.30802/AALAS-CM-22-000045.


The growing repertoire of genetic tools for dissecting chlamydial pathogenesis.

Banerjee A, Nelson D Pathog Dis. 2021; 79(5).

PMID: 33930127 PMC: 8112481. DOI: 10.1093/femspd/ftab025.


The Cervicovaginal Mucus Barrier.

Lacroix G, Gouyer V, Gottrand F, Desseyn J Int J Mol Sci. 2020; 21(21).

PMID: 33158227 PMC: 7663572. DOI: 10.3390/ijms21218266.


References
1.
Quinn T, Gaydos C, Shepherd M, Bobo L, Hook 3rd E, Viscidi R . Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA. 1996; 276(21):1737-42. View

2.
Pal S, Peterson E, de la Maza L . New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun. 2004; 72(7):4210-6. PMC: 427456. DOI: 10.1128/IAI.72.7.4210-4216.2004. View

3.
Haggerty C, Gottlieb S, Taylor B, Low N, Xu F, Ness R . Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010; 201 Suppl 2:S134-55. DOI: 10.1086/652395. View

4.
Gottlieb S, Deal C, Giersing B, Rees H, Bolan G, Johnston C . The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps. Vaccine. 2016; 34(26):2939-2947. PMC: 6759054. DOI: 10.1016/j.vaccine.2016.03.111. View

5.
Price M, Ades A, Soldan K, Welton N, Macleod J, Simms I . The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol Assess. 2016; 20(22):1-250. PMC: 4819202. DOI: 10.3310/hta20220. View